#AHA22
Connection Hub
Virtual Experience Access
Sessions Posters
Late-Breaking Science
Daily Coverage
Industry Highlights
Featured Exhibitors
Program
Previews
AHA21
Trials’ results suggest advancements in treatment approaches for AF and insight on the cardiac effects of coffee consumption
AHA21
Your Event Guide: Get ready for the virtual #AHA21
Download your #AHA21 Event Guide
AHA21
Plan your schedule now for Late-Breaking Science
Watch now
AHA21
Trials’ results suggest advancements in treatment approaches for AF and insight on the cardiac effects of coffee consumption
AHA21
Update on local and global hypertension science
-
AHA21
Late-Breaking Science: New information in cardiac disease
Information overload: Striving to improve care delivery through digital health and automated data.
AHA21
The latest science in heart failure
Four presenters build on the foundation of treatment and show advances in heart failure therapy.
Sponsored
Current issue of the Journal of the American Heart Association
AHA21
New drugs, indications in cardiovascular disease
Researchers present research regarding aspirin and dementia, early P2Y12 inhibitors, ticagrelor reversal agent and oral factor XIa.
AHA21
Monday's Late-Breaking Science presentations
AHA21
#AHA21 highlights for Day 1
AHA21
Valves, veins and new viewpoints in cardiothoracic surgery
Trials’ results shed light on a new device for extending vein graft durability, the timing of bypass surgery after Ticagrelor cessation and aortic valve replacement, and best practices for concomitant tricuspid valve repair.
AHA21
Sunday's Late-Breaking Science presentations
AHA21
Valves, veins and new viewpoints in cardiothoracic surgery
Trials’ results shed light on a new device for extending vein graft durability, the timing of bypass surgery after Ticagrelor cessation and aortic valve replacement, and best practices for concomitant tricuspid valve repair.
AHA21
Sunday's Late-Breaking Science presentations
AHA21
Preview of #AHA21 abstracts
Home
LBS coverage (2020) | Clinical trials that are making strides in digital interventions to improve CV patient care
Late-Breaking Science
LBS coverage (2020): AF trials reveal pragmatic screening and intervention opportunities
Late-Breaking Science
LBS coverage (2020) | COVID-19 cardiovascular disease registry documents relationships between CVD and COVID-19
Late-Breaking Science
LBS coverage (2020) | Trials shed light on fish oil, statin side effects and a new pathway to manage lipids
Late-Breaking Science
LBS coverage | Trials’ results suggest advancements in treatment approaches for CKD/T2D, TIA/minor ischemic stroke, pericarditis and ACS
Home
SAMSON results
Late-Breaking Science
LBS coverage (2020) | The latest clinical trial results in managing thrombosis in stents
Late-Breaking Science
LBS coverage (2020) | Clinical trials provide insights into CVD diagnosis in women, treatment for PCI and arrhythmia-associated bioprosthetic mitral valves
Late-Breaking Science
TIPS-3 + ASA results
Late-Breaking Science
GALACTIC-HF results
Late-Breaking Science
LBS coverage (2020) | Cost, access, adherence key challenges in global CVD prevention
